TrialFrontiers in immunology2026

Long-term outcomes of eltrombopag plus cyclosporine A in eltrombopag-exposed patients with glucocorticoid-resistant or -dependent primary immune thrombocytopenia: a prospective, multicenter, single-arm, phase II study with extended follow-up.

Yuhui Yuan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.